Benha University
Staff Search:
Go
Login
You are in:
Home
/
Publications
Prof.
mohamed
magdy
elsadek
atta
::
Publications:
Research Fields
HEPATOLOGY GASTROENTEROLOGY & INFECTIOUS DISEASES
Number of publications is 57
Title
1-
Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients
Abstract
'
|
Full paper
2-
Early rebleeding and mortality in post HCV cirrhotic patients with esophageal variceal bleeding after band ligation: predictive factors and value of vascular endothelial growth factor.
3-
Hypothyroidism is the prevalent thyroid dysfunction encountered during combined Interferon / Ribavirin (IFN / RBV) therapy in chronic hepatitis C patient.
4-
Lymphocyte subgroups , tumour necrosis factor alpha and interleukin-6 in ascitic fluid and serum of patients with and sontaneous bacterial peritonitis at Benha university hospital.Egyptian
5-
Tolemerase Reverse Transcriptase Gene Expression as a Tumor Marker for Hepatocellular Carcinoma.
Abstract
'
|
Full paper
6-
Assessment of eight non-invasive markers of liver fibrosis in Egyptian patients with chronic hepatitis C.
Abstract
'
|
Full paper
7-
Seroprevelance of Toxoplasmosis among Females in Rural Areas, Qalubeya Governorate.
8-
Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma.
Abstract
9-
Prognostic value of serum anti- P53 antibody in Egyptian patients with hepatocellular carcinoma.
10-
Study of pancreatic enzymes in patients with liver diseases.
11-
Spontaneous bacterial peritonitis: a clinical and microbiological study.
12-
Non-invasive prediction of esophageal variceal presence and bleeding by duplex ultrasonography.
13-
Low Incidence of Helicobacter pylori Infection in Patients with Duodenal Ulcer and Chronic Liver Disease Scandinavian
Abstract
14-
Study of Helicobacter Pylori in dyspepsia with and without non-steroidal anti-inflammatory drugs (NSAIDs) intake and/or chronic liver disease (CLD) with the effect of therapy.
15-
Shistosomiases-Associated glomerulopathy a field studies from Nile delta. African
16-
Serum hepatocyte growth factor in shistosomal and non shistosomal chronic liver diseases.
Abstract
'
|
Full paper
17-
Signficance of alfa-fucosidase and n-acetylneuraminic acid as markers for hepatocellular carcinoma.
18-
The importance of detecting circulating Toxoplasma antigens in human cases.
Abstract
19-
High prevalence of hepatitis C virus RNA in saliva of patients with chronic HCV infection.
20-
Evaluating the detection of circulating filarial antigen in diagnosis of bancroftian filariasis and filarial hydrocele.
Abstract
21-
Evaluation of ELISA in detection of circulating antigen of bancroftian filariasis.
Abstract
22-
Detection of Ccryptosporidium antigen in stool sample among diarrhoeic children.
Abstract
23-
The value of splenomegaly in predicting the source of upper gastrointestinal bleeding.
24-
Toxoplasma infections distinguished by avidity of IgG.
25-
Sensitivity and specificity of alpha-L-fucosidase as a tumor marker in early diagnosis of hepatocellular carcinoma.
26-
A study of Helicobact pylori in patients with and without chronic liver disease.
27-
Bleeding oesophageal varices in Egypt: Analysis of 362 patients.
28-
Effects of propranolol therapy on portal haemodynamics in patient with hepatic schistosomiasis.
29-
Effect of labetalol on portal pressure and estimated hepatic blood flow in patients with schistosomal hepatic fibrosis.
30-
Responders and non-responders to interferon in patient with hepatitis C infection: A comparative retrospective study.
31-
The effect of treatment on circulating schistosomal antigens and hepatic periportal fibrosis in children with schistosomiasis mansoni.
32-
Alpha interferon in chronic viral hepatitis: A controlled study.
33-
Bleeding oesophageal varices associated with hepatic schistosomiasis in Egypt.
34-
Endoscopic mucosal lesions in diagnosis of giardiasis.
35-
Endoscopic and histopathologic appearance of the gastric mucosa in patients with chronic liver diseases.
36-
A study of the hormonal immunity and (HLA) tissue typing in different clinical forms of amoebiasis.
37-
Serum prealbumin concentrations in acute and chronic liver diseases.
38-
Gastroesophageal endoscopic features in patients with chronic liver disease.
39-
Efficacy of two different dose levels of ofloxacin in drug resistant cases of enteric fever.
40-
Effect of sclerotherapy versus splenectomy – devascularization on haemostatic picture of patients with bleeding oesophageal varices.
41-
Value of duplex ultrasonography in schistosomal hepatic lesions.
42-
Study of HBV markers and HLA typing in chronic liver diseases (CLD).
43-
Atypical virus B hepatitis in Egypt.
44-
Peptic ulcer in chronic liver disease patients: A novel approach.
45-
ELISA in detection of Entamoeba histolytica antigens in stools.
46-
Study of plasma level of fibronectin in different stages of schistosomiasis.
47-
Evaluation of different doses of praziquantel in the cure of intestinal schistosomiasis.
48-
Prevelance of hepatitis B surface antigen in serum and ascetic fluid of patients with chronic liver diseases.
49-
The value of salt restriction in the treatment of hepatic ascites.
50-
Gastric fluid acidity in peptic lesions.
51-
Serological and parasitological examination of some patients with manifestations suggestive leishmaniasis.
52-
The effect of propranolol on portal hypertension and prevention of recurrent variceal bleeding in schistosomal and non-schistosomal patients.
53-
Hepatitis B surface antigenemia in hepatosplenic patients with active schistosomiasis.
54-
Urinary infections associated with chronic salmonellosis.
55-
Eosinophilia and schistomal egg count.
56-
Evaluation of the different methods of diagnosing schistosomiasis.
57-
Endoscopic and immunohistopathological study of gastric, duodenal, and colonic mucosa in schistosomal polyposis